Changes are being made to medicare drug payment plans, potentially impacting the cost and availability of certain medications. Some beneficiaries may see savings or increased access to certain drugs, including obesity and breast cancer treatments. However, the extent of these changes and their effects on medicare recipients remain unclear, with reports of both increased savings and reduced options.